{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T12:00:42Z","timestamp":1788091242302,"version":"build-2803163510"},"reference-count":152,"publisher":"Informa UK Limited","issue":"2","funder":[{"name":"Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Immunology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1080\/1744666x.2023.2270737","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T10:38:04Z","timestamp":1697452684000},"page":"197-209","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["A comprehensive review of dermatomyositis treatments - from rediscovered classics to promising horizons"],"prefix":"10.1080","volume":"20","author":[{"given":"Ecem","family":"Sevim","sequence":"first","affiliation":[{"name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Kobrin","sequence":"additional","affiliation":[{"name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Casal-Dominguez","sequence":"additional","affiliation":[{"name":"Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA"},{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iago","family":"Pinal-Fernandez","sequence":"additional","affiliation":[{"name":"Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA"},{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,10,17]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30254-0"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40674-022-00198-1"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41964"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead400"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008443"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23188"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40674-021-00186-x"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex413"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab260"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-222441"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42474"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42512"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20464"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008128"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216599"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-021-02365-5"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000540"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200679"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-223873"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.161448"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120621"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/290797"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001756"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.03.007"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1900045"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2004.01510.x"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16498"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcv196"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.09.016"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.1429"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2004.00115.x"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200607060-00002"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.5.5.1083"},{"issue":"1","key":"e_1_3_4_36_1","first-page":"50","article-title":"Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis","volume":"12","author":"Yoshimasu T","year":"2002","unstructured":"Yoshimasu T, Ohtani T, Sakamoto T, et al. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Eur J Dermatol. 2002 Jan;12(1):50\u201352.","journal-title":"Eur J Dermatol"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630310018509"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1159\/000079903"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1051609"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.03.003"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab421"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003643.pub4"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90037-7"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-003-0025-9"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2019.05.023"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3704"},{"issue":"5","key":"e_1_3_4_47_1","first-page":"858","article-title":"Efficacy and adverse effects of methotrexate compared with azathioprine in the antisynthetase syndrome","volume":"37","author":"Casal-Dominguez M","year":"2019","unstructured":"Casal-Dominguez M, Pinal-Fernandez I, Huapaya J, et al. Efficacy and adverse effects of methotrexate compared with azathioprine in the antisynthetase syndrome. Clin Exp Rheumatol. 2019 Sep;37(5):858\u2013861.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel336"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000208416.32471.c0"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.1.65"},{"issue":"6","key":"e_1_3_4_51_1","first-page":"1542","article-title":"Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases","volume":"27","author":"Gelber AC","year":"2000","unstructured":"Gelber AC, Nousari HC, Wigley FM. Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases. J Rheumatol. 2000 Jun;27(6):1542\u20131545.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1159\/000051674"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.04.003"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20269"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac404"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31818d094b"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0012-3692(15)50949-5"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20212"},{"issue":"1","key":"e_1_3_4_59_1","first-page":"41","article-title":"Treatment of an acute dermatomyositis with cyclosporin a","volume":"12","author":"Zabel P","year":"1984","unstructured":"Zabel P, Leimenstoll G, Gross WL. Treatment of an acute dermatomyositis with cyclosporin a. Immun Infekt. 1984 Feb;12(1):41\u201342.","journal-title":"Immun Infekt"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.45.7.612-b"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92456-2"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.11.1007"},{"issue":"8","key":"e_1_3_4_63_1","first-page":"1424","article-title":"Cyclosporin a therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases","volume":"23","author":"Zeller V","year":"1996","unstructured":"Zeller V, Cohen P, Prieur AM, et al. Cyclosporin a therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases. J Rheumatol. 1996 Aug;23(8):1424\u20131427.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1080\/030097400750001897"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01021-1"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-004-1497-7"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7753(06)72367-3"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-2044-y"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu166"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12931"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez394"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13978"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.210322"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-008-0973-2"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1403014"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292704"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2117912"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.12.003"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.805705"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-016-0112-6"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15607"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101321"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20849"},{"issue":"6","key":"e_1_3_4_84_1","first-page":"1009","article-title":"Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. A report of 4 cases and review of the literature","volume":"27","author":"Rios Fern\u00e1ndez R","year":"2009","unstructured":"Rios Fern\u00e1ndez R, Callejas Rubio JL, S\u00e1nchez Cano D, et al. Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. A report of 4 cases and review of the literature. Clin Exp Rheumatol. 2009 Nov;27(6):1009\u20131016.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.05.068"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37754"},{"issue":"2","key":"e_1_3_4_87_1","first-page":"162","article-title":"The use of rituximab in the management of refractory dermatomyositis","volume":"16","author":"Kuye IO","year":"2017","unstructured":"Kuye IO, Smith GP. The use of rituximab in the management of refractory dermatomyositis. J Drugs Dermatol. 2017 Feb 1;16(2):162\u2013166.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew396"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0701-9"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00791-1"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/hxin6o"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.0866"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41602"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa360"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.08.025"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218690"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.962585"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.10.055"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1412997"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy105"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)80263-7"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.2549"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.9.1231"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212047"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.3.561"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211751"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2011.11.057"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4073879"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key146"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42450"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.048744"},{"issue":"9","key":"e_1_3_4_112_1","first-page":"1802","article-title":"Use of etanercept in the treatment of dermatomyositis: a case series","volume":"33","author":"Iannone F","year":"2006","unstructured":"Iannone F, Scioscia C, Falappone PC, et al. Use of etanercept in the treatment of dermatomyositis: a case series. J Rheumatol. 2006 Sep;33(9):1802\u20131804.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.077974"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1159\/000114036"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22198"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.10.010"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22477"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01220.x"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12999"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2002.01409.x"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.3917"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12720"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.5070\/D3256044451"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.08.014"},{"issue":"6","key":"e_1_3_4_125_1","first-page":"1011","article-title":"Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity","volume":"35","author":"de Souza RC","year":"2017","unstructured":"de Souza RC, de Souza FHC, Miossi R, et al. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity. Clin Exp Rheumatol. 2017 Nov;35(6):1011\u20131013.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202857"},{"issue":"6","key":"e_1_3_4_127_1","first-page":"904","article-title":"Interleukin-1 receptor antagonist for refractory anti-MDA5 clinically amyopathic dermatomyopathy","volume":"33","author":"Groh M","year":"2015","unstructured":"Groh M, Rogowska K, Monsarrat O, et al. Interleukin-1 receptor antagonist for refractory anti-MDA5 clinically amyopathic dermatomyopathy. Clin Exp Rheumatol. 2015 Nov;33(6):904\u2013905.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.03.029"},{"key":"e_1_3_4_129_1","unstructured":"Corbus Pharmaceuticals Announces Topline results from DETERMINE phase 3 study of Lenabasum for treatment of Dermatomyositis [Internet]. 2021. Available from: https:\/\/www.globenewswire.com\/news-release\/2021\/06\/24\/2252567\/0\/en\/Corbus-Pharmaceuticals-Announces-Topline-Results-from-DETERMINE-Phase-3-Study-of-Lenabasum-for-Treatment-of-Dermatomyositis.html"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker152"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11493"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223792"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103375"},{"issue":"6","key":"e_1_3_4_134_1","first-page":"658","article-title":"Combined steroid, methotrexate and chlorambucil therapy for steroid-resistant dermatomyositis","volume":"9","author":"Cagnoli M","year":"1991","unstructured":"Cagnoli M, Marchesoni A, Tosi S. Combined steroid, methotrexate and chlorambucil therapy for steroid-resistant dermatomyositis. Clin Exp Rheumatol. 1991 Nov;9(6):658\u2013659.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360305"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.05.044"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.26.021607.090357"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214229"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216246"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez020"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02017-5"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00023-5"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.3109\/03009740903096622"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198602063140601"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww122"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180060"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(23)00003-6"},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.887"},{"key":"e_1_3_4_149_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2019-0299"},{"key":"e_1_3_4_150_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000951"},{"key":"e_1_3_4_151_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202249851"},{"issue":"1","key":"e_1_3_4_152_1","first-page":"77","article-title":"OP0117\u2005proteasome inhibition as a new treatment for dermatomyositis: results of a drug repurposing analysis based on the transcriptomic signature of patients\u2019 perifascicular fibers validated in pre-clinical models","volume":"82","author":"Debrut L","year":"2023","unstructured":"Debrut L, Giannini M, Keime C, et al. OP0117\u2005proteasome inhibition as a new treatment for dermatomyositis: results of a drug repurposing analysis based on the transcriptomic signature of patients\u2019 perifascicular fibers validated in pre-clinical models. Ann Rheumatic Dis. 2023;82(Suppl 1):77\u201377.","journal-title":"Ann Rheumatic Dis"},{"key":"e_1_3_4_153_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead250"},{"key":"e_1_3_4_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103105"}],"container-title":["Expert Review of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1744666X.2023.2270737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T04:55:33Z","timestamp":1727240133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1744666X.2023.2270737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":152,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1080\/1744666X.2023.2270737"],"URL":"https:\/\/doi.org\/10.1080\/1744666x.2023.2270737","relation":{},"ISSN":["1744-666X","1744-8409"],"issn-type":[{"value":"1744-666X","type":"print"},{"value":"1744-8409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-07-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}